S-C04
Amyloidosis: Should Our Treatment Approaches Be More Personalized?

Track: BMT Tandem "Scientific" Meeting
Thursday, February 27, 2014: 10:30 AM-12:00 PM
Texas B (Gaylord Texan)
Chair:
Steven M. Devine, MD

Disclosures:
S. M. Devine, Nothing To Disclose

When is High Dose Chemotherapy the Best Choice?
Angela Dispenzieri, MD, Mayo Clinic Rochester, The William J. Von Liebig Transplant Center

Biomarkers to Assess Prognosis
Steven M. Devine, MD, Ohio State Medical Center